title: The efficacy of caelyx and hyperthermia for anticancer treatment.
abstract: The efficacy of hyperthermia and caelyx as single modalities of therapy in progressed and refractory cancer of different primary sites is well known. Nevertheless, it remains question mark whether they can work together to that direction. We have recently published a paper which demonstrates some excellent results in treatment of recurrent breast cancer with hyperthermia in conjunction with caelyx and radiotherapy. The mechanism of action of those different therapeutic options and a review in literature are presented in this paper. Despite the limited number of studies, they all show that the combined treatment is effective and well tolerated. It would be interesting to mention another treatment patent of cancer which can be done by a combination of non-ionizing radiation and androgen deprivation. Also, combined therapy for tumors and tumor metastases comprised administration of integrin ligands and co-therapeutic agents have synergistic efficacy in isolated organ perfusion. Finally, the treatment of solid tumors can be done by glycolytic inhibitors.
authors.affiliation: Radiatiotherapy Unit, 2nd Department of Radiology, University of Athens Medical School, Attikon University Hospital Greece.
authors.forename: Vasilios E
authors.initials: VE
authors.lastname: Kouloulias
authors.forename: Georgios V
authors.initials: GV
authors.lastname: Koukourakis
authors.forename: Aristides K
authors.initials: AK
authors.lastname: Petridis
authors.forename: Ioannis
authors.initials: I
authors.lastname: Kouvaris
authors.forename: Athanasios D
authors.initials: AD
authors.lastname: Gouliamos
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003627:Data Interpretation, Statistical; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D010330:Patents as Topic
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin